Literature DB >> 32709750

Survivin in breast cancer-derived exosomes activates fibroblasts by up-regulating SOD1, whose feedback promotes cancer proliferation and metastasis.

Kangdi Li1, Ting Liu1, Jie Chen1, Huying Ni1, Wenhua Li2.   

Abstract

Cancer-associated fibroblasts (CAFs) play a critical role in the coevolution of breast tumor cells and their microenvironment by modifying cellular compartments and regulating cancer cell functions via stromal-epithelial dialogue. However, the relationship and interaction between stromal and epithelial cells is still poorly understood. Herein, we revealed that breast cancer cells have a stronger ability to activate fibroblasts and transform them into myofibroblasts (CAF-like) than normal breast epithelial cells, and this stronger ability occurs through paracrine signaling. In turn, myofibroblasts promote the proliferation, epithelial-to-mesenchymal transition (EMT), and stemness of breast cancer cells. Detailed regulatory mechanisms showed that, compared with normal cells, Survivin is overexpressed in breast cancer cells and secreted extracellularly in the form of exosomes, which are then internalized by fibroblasts. Breast cancer cell-derived survivin up-regulates SOD1 expression in fibroblasts and then converts them into myofibroblasts, conversely inducing breast cancer progression in vitro and in vivo Thus, our results indicate that survivin acts as an activator of the tumor microenvironment and that SOD1 up-regulation in fibroblasts can promote breast cancer progression. These results suggest that targeting survivin and SOD1 may be a potential therapeutic strategy for breast cancer.
© 2020 Li et al.

Entities:  

Keywords:  SOD1; breast cancer; exosome; exosome (vesicle); myofibroblasts; survivin; tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 32709750      PMCID: PMC7535909          DOI: 10.1074/jbc.RA120.013805

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 2.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

Review 3.  Is survivin the potential Achilles' heel of cancer?

Authors:  Alvaro Lladser; Carlos Sanhueza; Rolf Kiessling; Andrew F G Quest
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

Review 4.  Accessories to the crime: functions of cells recruited to the tumor microenvironment.

Authors:  Douglas Hanahan; Lisa M Coussens
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

5.  Survivin mediates self-protection through ROS/cdc25c/CDK1 signaling pathway during tumor cell apoptosis induced by high fluence low-power laser irradiation.

Authors:  Jiru Chu; Shengnan Wu; Da Xing
Journal:  Cancer Lett       Date:  2010-06-25       Impact factor: 8.679

6.  Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast.

Authors:  Christina Scheel; Elinor Ng Eaton; Sophia Hsin-Jung Li; Christine L Chaffer; Ferenc Reinhardt; Kong-Jie Kah; George Bell; Wenjun Guo; Jeffrey Rubin; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2011-06-10       Impact factor: 41.582

7.  Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.

Authors:  Maria T Diaz-Meco; Jorge Moscat; Tania Valencia; Ji Young Kim; Shadi Abu-Baker; Jorge Moscat-Pardos; Christopher S Ahn; Miguel Reina-Campos; Angeles Duran; Elias A Castilla; Christian M Metallo
Journal:  Cancer Cell       Date:  2014-07-04       Impact factor: 31.743

Review 8.  New wirings in the survivin networks.

Authors:  D C Altieri
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

Review 9.  Endocrine-responsive breast cancer and strategies for combating resistance.

Authors:  Simak Ali; R Charles Coombes
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

10.  Exosomes: looking back three decades and into the future.

Authors:  Clifford V Harding; John E Heuser; Philip D Stahl
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

View more
  15 in total

Review 1.  The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer.

Authors:  Xinyi Wang; Jing Huang; Wenjie Chen; Genpeng Li; Zhihui Li; Jianyong Lei
Journal:  Exp Mol Med       Date:  2022-09-22       Impact factor: 12.153

Review 2.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

Review 3.  Therapeutic Potential of Exosomes in Pulmonary Fibrosis.

Authors:  Linshen Xie; Ye Zeng
Journal:  Front Pharmacol       Date:  2020-12-04       Impact factor: 5.810

Review 4.  Exosomal miRNAs and lncRNAs: The Modulator Keys of Cancer-Associated Fibroblasts in the Genesis and Progression of Malignant Neoplasms.

Authors:  Julio César Villegas-Pineda; Mélida Del Rosario Lizarazo-Taborda; Adrián Ramírez-de-Arellano; Ana Laura Pereira-Suárez
Journal:  Front Cell Dev Biol       Date:  2021-11-29

5.  Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses.

Authors:  Jiya Eerdeng; Samir Akre; Du Jiang; Humberto Contreras-Trujillo; Jorge Contreras; Basia Gala; Mary C Vergel-Rodriguez; Yeachan Lee; Aparna Jorapur; Areen Andreasian; Lisa Harton; Charles S Bramlett; Anna Nogalska; Gang Xiao; Jae-Woong Lee; Lai N Chan; Markus Müschen; Akil A Merchant; Rong Lu
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 14.919

Review 6.  Nuclear SOD1 in Growth Control, Oxidative Stress Response, Amyotrophic Lateral Sclerosis, and Cancer.

Authors:  Joyce Xu; Xiaoyang Su; Stephen K Burley; X F Steven Zheng
Journal:  Antioxidants (Basel)       Date:  2022-02-21

Review 7.  Exosomes Regulate the Epithelial-Mesenchymal Transition in Cancer.

Authors:  Jingwen Jiang; Jiayu Li; Xiumei Zhou; Xueqin Zhao; Biao Huang; Yuan Qin
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

8.  Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7.

Authors:  Ziqian Yan; Zhimei Sheng; Yuanhang Zheng; Ruijun Feng; Qinpei Xiao; Lihong Shi; Hongli Li; Chonggao Yin; Hao Luo; Chong Hao; Wenhao Wang; Baogang Zhang
Journal:  Cell Death Dis       Date:  2021-12-01       Impact factor: 8.469

9.  The Activation of Mesenchymal Stem Cells by Glioblastoma Microvesicles Alters Their Exosomal Secretion of miR-100-5p, miR-9-5p and let-7d-5p.

Authors:  Delphine Garnier; Edward Ratcliffe; Joséphine Briand; Pierre-François Cartron; Lisa Oliver; François M Vallette
Journal:  Biomedicines       Date:  2022-01-06

Review 10.  Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment.

Authors:  Mark Samuels; Chiara Cilibrasi; Panagiotis Papanastasopoulos; Georgios Giamas
Journal:  Biomolecules       Date:  2022-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.